LY 2157299

Details:

Product Name: LY 2157299
Synonyms: LY 2157299;4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide;6-QuinolinecarboxaMide, 4-[5,6-dihydro-2-(6-Methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-;4-[2-(6-Methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxaMideorLY2157299;Galunisertib,LY2157299;4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide;2-(6-methylpyridin-2-yl)-3-(6-aminocarbonylquinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole;4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide LY 2157299
CAS: 700874-72-2
MF: C22H19N5O
MW: 369.43
EINECS:
Product Categories: Inhibitors;Smad;TGF-beta
Mol File: 700874-72-2.mol
LY 2157299 Structure
LY 2157299 Chemical Properties
Boiling point  619.0±55.0 °C(Predicted)
density  1.40
Fp  328.162℃
pka 15.27±0.30(Predicted)
CAS DataBase Reference 700874-72-2
Safety Information
Hazard Codes  T
Risk Statements  25
Safety Statements  45
HS Code  29334900
MSDS Information
LY 2157299 Usage And Synthesis
Uses LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1 kinase (IC50 = 56 nM). It has been used to study the role of TGF-β signaling in chemotherapy-induced expansion of cancer stem-like cells in triple negative breast cancer cell lines and xenografts. LY2157299 has also been shown to inhibit the migration and tumor growth of hepatocellular carcinoma cell lines by disrupting Smad-2 phosphorylation.[Cayman Chemical]